First treatment for serious chronic lung disease

View source ↗

Summary

EMA approves Brinsupri as the first treatment for serious chronic lung disease, showing reduced and delayed pulmonary exacerbations in non-cystic fibrosis bronc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• BRINSUPRI (BRENSOCATIB)

Snippet

Brinsupri significantly reduces and delays the occurrence of pulmonary exacerbations in patients with non-cystic fibrosis bronchiectasis